PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Studies in humans have evidenced activity in improving lipid profiles [PMID:40927271].
A systematic review of 21 trials (4558 patients) evaluated RYR's efficacy on blood pressure, lipid profile, and C-reactive protein, noting that 'RYR plus conventional therapy' exhibited effects, though many trials had low methodological quality [PMID:26167669].
In high-fat diet-induced obese mice, red koji reduced body weight gain, fat accumulation, and blood glucose levels, and increased glucose uptake and GLUT4 protein expression in L6 myotube cells [PMID:25237599].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 22864970 (2012) — Biochemical aspects of red koji and tofuyo prepared using Monascus fungi. · Applied microbiology and biotechnology
- 2.PMID: 38294276 (2024) — Unveiling the potential of red koji polysaccharides: biosynthesis, extraction, and multifaceted biological activities. · Journal of the science of food and agriculture
- 3.PMID: 26167669 (2017) — The effects of red yeast rice dietary supplement on blood pressure, lipid profile, and C-reactive protein in hypertension: A systematic review. · Critical reviews in food science and nutrition
- 4.PMID: 40927271 (2025) — Monascus purpureus Red Yeast Rice: A Review of the in vitro and in vivo Pharmacological Activities, Studies in Humans, and Case Reports. · Clinical pharmacology : advances and applications
- 5.PMID: 31462600